验证数据展示
经过测试的应用
| Positive WB detected in | HeLa cells, mouse lung tissue, SH-SY5Y cells |
| Positive IHC detected in | human colon tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | U2OS cells |
推荐稀释比
| 应用 | 推荐稀释比 |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
发表文章中的应用
| WB | See 4 publications below |
| IHC | See 6 publications below |
产品信息
18098-1-AP targets B3GNT3 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
| 经测试应用 | WB, IHC, IF/ICC, ELISA Application Description |
| 文献引用应用 | WB, IHC |
| 经测试反应性 | human, mouse |
| 文献引用反应性 | human |
| 免疫原 | B3GNT3 fusion protein Ag12061 种属同源性预测 |
| 宿主/亚型 | Rabbit / IgG |
| 抗体类别 | Polyclonal |
| 产品类型 | Antibody |
| 全称 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
| 别名 | Beta-1,3-N-acetylglucosaminyltransferase 3, Beta-1,3-Gn-T3, Beta-1,3-GalTase 8, Beta-1,3-galactosyltransferase 8, Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase |
| 计算分子量 | 372 aa, 43 kDa |
| 观测分子量 | 43 kDa |
| GenBank蛋白编号 | BC066876 |
| 基因名称 | B3GNT3 |
| Gene ID (NCBI) | 10331 |
| RRID | AB_10596928 |
| 偶联类型 | Unconjugated |
| 形式 | Liquid |
| 纯化方式 | Antigen affinity purification |
| UNIPROT ID | Q9Y2A9 |
| 储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
| 储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3) is a type II transmembrane protein located in the Golgi apparatus and contributes to the regulation of L-selectin ligand function, lymphocyte trafficking, and T cell homing. B3GNT3 is overexpressed in breast cancer, and also plays a critical role in the aggressiveness of pancreatic cancer (PMID: 33718036, 30466404). Western blot analysis detected B3GNT3 at an apparent molecular mass of 43 kDa.
实验方案
| Product Specific Protocols | |
|---|---|
| WB protocol for B3GNT3 antibody 18098-1-AP | Download protocol |
| IHC protocol for B3GNT3 antibody 18098-1-AP | Download protocol |
| IF protocol for B3GNT3 antibody 18098-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
发表文章
| Species | Application | Title |
|---|---|---|
Cancer Cell Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. | ||
Transl Lung Cancer Res Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma. | ||
PLoS One B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. | ||
BMC Bioinformatics A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma | ||
J Clin Pathol B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer. | ||
Oncol Lett B3GNT3: A prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinoma. |
